Targeting KMT6-mediated histone methylation KMT6 with the GSK343 inhibitor in HepG2 repressed cancer cell growth, suggesting that this histone methylation mark is involved in regulation of genes important for the survival of liver cancer cells [49]. Here, EZH2 is linked to liver cancer.